Guardant Health
GH
#3091
Rank
C$5.63 B
Marketcap
$45.64
Share price
5.39%
Change (1 day)
43.50%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - P/B ratio

P/B ratio as of November 2024 : -68.3

According to Guardant Health 's latest financial reports the company has a price-to-book ratio of 6.37916.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Guardant Health - P/B ratio (from 2018 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3120.7-55.31%
2022-12-3146.3193.7%
2021-12-3115.865.85%
2020-12-319.509.84%
2019-12-318.6540.92%
2018-12-316.14
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
26.1-138.23%๐Ÿ‡บ๐Ÿ‡ธ USA
1.03-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA